The burden of psychotropic drug prescribing in people with dementia: a population database study
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: to compare psychotropic prescribing in older people with dementia and the general elderly population. DESIGN AND SETTING: retrospective population database study in 315 General Practices. SUBJECTS: there were 271,365 patients aged > or = 65, of which 10,058 (3.7%) recorded as having dementia. METHODS: epidemiology of psychotropic prescribing in older people with and without dementia; multilevel modelling of patient and practice characteristics associated with antipsychotic prescribing. RESULTS: people with dementia were currently prescribed an antipsychotic drug (17.7%), an antidepressant (28.7%) and a hypnotic/anxiolytic (16.7%). Compared to the general elderly population, antipsychotic prescribing was 17.4 [95% confidence interval (CI) 16.4-18.4], antidepressant prescribing 2.7 (95% CI 2.6-1.8) and hypnotic/anxiolytics 2.2 (95% 2.1-2.3) times more likely in people with dementia. Most antipsychotic prescribing in people with dementia was prolonged (> 16 weeks). Patients living in more deprived areas and registered with larger and more remote practices were more likely to be prescribed prolonged antipsychotics. CONCLUSIONS: over one in six patients are currently prescribed antipsychotic drugs known to be of little benefit and causing significant harm, with other psychotropics equally commonly used. Changing this will require investment in services to support alternative management strategies for people with behavioural and psychological disturbance associated with dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schneider, L. S., Dagerman, K. S., & Insel, P. (2005) · JAMA · doi:10.1001/jama.294.15.1934 · Cited by 1,671 · cited 1×
“Initial guidance in 2004 focused on risperidone and olanzapine which were found to triple the risk of stroke [6] with a small but significant increase in mortality [4, 7].”
BackgroundAntipsychotic Drug Use and Mortality in Older Adults with Dementia
Gill, S. S., Bronskill, S. E., Normand, S.-L. T., Anderson, G. M., Sykora, K., Lam, K., Bell, C. M., Lee, P. E., Fischer, H. D., Herrmann, N., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-11-200706050-00006 · Cited by 624
Ballard, C., Hanney, M. L., Theodoulou, M., Douglas, S., McShane, R., Kossakowski, K., Gill, R., Juszczak, E., Yu, L.-M., & Jacoby, R. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70295-3 · Cited by 567
Management of agitation and aggression associated with Alzheimer disease
Ballard, C. G., Gauthier, S., Cummings, J. L., Brodaty, H., Grossberg, G. T., Robert, P., & Lyketsos, C. G. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.39 · Cited by 404 · cited 5×
“A common response to BPSD is to prescribe psychotropic drugs including antipsychotics, for which there is strong evidence of a weak-to-moderate effect on behaviour, although trials are based on typically short ( 12 week) follow-up, and impact largely relates to reductions in aggression rather than the full range of sy…”
BackgroundInfluentialSchneeweiss, S., Setoguchi, S., Brookhart, A., Dormuth, C., & Wang, P. S. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.061250 · Cited by 366
Drug-Induced Cognition Disorders in the Elderly: Incidence, Prevention and Management
Gray, S. L., Lai, K. V., & Larson, E. B. (1999) · Drug Safety · doi:10.2165/00002018-199921020-00004 · Cited by 190 · cited 1×
“7% of people with dementia were currently being prescribed tricyclic antidepressants, which significantly worsen cognition because of their anticholinergic effects [24].”
Background
Cited by
Individual music therapy for agitation in dementia: an exploratory randomized controlled trial
Ridder, H. M. O., Stige, B., Qvale, L. G., & Gold, C. (2013) · Aging & Mental Health · doi:10.1080/13607863.2013.790926 · Cited by 226
Beerens, H. C., Zwakhalen, S. M. G., Verbeek, H., Ruwaard, D., & Hamers, J. P. H. (2013) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2013.02.005 · Cited by 219
Clague, F., Mercer, S. W., McLean, G., Reynish, E., & Guthrie, B. (2016) · Age and Ageing · doi:10.1093/ageing/afw176 · Cited by 195
“In particular, previous work using the same data set as this analysis has shown that people with dementia are 17 times more likely to be prescribed an antipsychotic and twice as likely to be prescribed an antidepressant or a hypnotic/anxiolytic than older people without dementia [25].”
MethodSelf-citationIdentifying potentially inappropriate prescribing in older people with dementia: a systematic review
Hukins, D., Macleod, U., & Boland, J. W. (2019) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-018-02612-x · Cited by 84
Knowledge of Dementia Among the Australian Health Workforce: A National Online Survey
Annear, M. J. (2020) · Journal of Applied Gerontology · doi:10.1177/0733464817752085 · Cited by 64
“For example, the harms of psychotropic medications (also known as antipsychotics) for controlling BPSD are well known and include stroke and premature death (Gill et al., 2007; Guthrie et al., 2010).”
Background
Metadata
- Authors
- Guthrie, B., Clark, S. A., & McCowan, C.
- Venue
- Age and Ageing
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-07-12
- Volume
- 39
- Issue
- 5
- Pages
- 637-642
- ISSN
- 0002-0729 (ISSN-L)
- 1468-2834
- OpenAlex
- W2152096880
- Cited by
- 112
- References
- 6
- FWCI
- 3.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.